Results 181 to 190 of about 99,788 (345)

The Role of SAMHD1 in Viral Resistance and Transduction Efficiency Challenges in Pediatric Hematological Malignancies: Mechanistic Insights and Clinical Perspectives

European Journal of Haematology, EarlyView.
SAMHD1 regulates intracellular dNTP pools, influencing lentiviral transduction, gene therapy efficiency, and disease progression in pediatric hematological malignancies. Integrated bioinformatics and targeted strategies, including CRISPR and pharmacological inhibition, highlight its therapeutic potential.
Waseem Alzamzami
wiley   +1 more source

Trends in Survival and Cure Indicators of Thin and Thick Cutaneous Malignant Melanoma in Italy. [PDF]

Cancer Med
Mancini S, Toffolutti F, Zamagni F, Bucchi L, Crocetti E, Giudici F, Bella F, Benedetto A, Bidoli E, Carone S, Carrozzi G, Cascone G, Cavallo R, Cozzi I, Falcini F, Ferretti S, Iacovacci S, Mantovani W, Mian M, Michiara M, Rocino MT, Scuderi T, Ridolfi L, Stanganelli I, Guzzinati S, Dal Maso L, AIRTUM Working Group.   +26 more
europepmc   +1 more source

Genetic Characteristics of Primary Cutaneous Malignant Melanoma in Koreans Compared With Western Populations. [PDF]

In Vivo, 2023
Jang H, Ryu HJ, Kim SK.
europepmc   +1 more source

The epidemiology of cutaneous malignant melanoma in Nova Scotia

, 2006
Andrew Howlett, Ron AD Dewar
openalex   +1 more source

Behind the scenes: how the EMILIN/Multimerin family shapes the cancer landscape

The FEBS Journal, EarlyView.
The EMILIN/Multimerin family members regulate key hallmarks of cancer—including apoptosis, angiogenesis, metastasis, and tumor microenvironment remodeling. As indicated, their function in immune evasion, drug resistance, and metabolic reprogramming remains largely unexplored.
Evelina Poletto, Naike Casagrande, Emanuele Di Siena, Greta Carobolante, Lucrezia Camicia, Giorgia Schinello, Samanta Muzzin, Enrica Timis, Paola Spessotto, Maurizio Mongiat   +9 more
wiley   +1 more source

A bibliometric systematic review of extracellular vesicles in cutaneous malignant melanoma from 2005 to 2025. [PDF]

Front Oncol
Christodoulides N, Bollard S, Chabria Y, O'Driscoll L, Potter S.   +4 more
europepmc   +1 more source

Lnc-PKNOX1-1 inhibits tumor progression in cutaneous malignant melanoma by regulating NF-κB/IL-8 axis. [PDF]

Carcinogenesis, 2023
Hong A, Cao M, Li D, Wang Y, Zhang G, Fang F, Zhao L, Wang Q, Lin T, Wang Y.   +9 more
europepmc   +1 more source

Cutaneous Metastases from Malignant Melanoma: Clinical Features and New Therapeutic Perspectives

, 2011
Paola Savoia, Paolo Fava, Maria Grazia
openalex   +2 more sources

COPS8 in cutaneous melanoma: an oncogene that accelerates the malignant development of tumor cells and predicts poor prognosis [PDF]

, 2020
Liangliang Sun
openalex   +1 more source

Targeting the microbiota‐miRNA‐protease axis: A new therapeutic avenue in melanoma

The FEBS Journal, EarlyView.
Modulation of extracellular matrix (ECM) turnover is central to melanoma progression and metastasis, driven largely by ECM proteases. This review highlights the epigenetic regulation of ECM proteases by microRNAs and their roles in melanoma growth, invasion, and immune modulation.
Elias N. Katsoulieris, Paraskevi Ioannou, Nikolaos A. Afratis   +2 more
wiley   +1 more source